$GTCH The AI Eye Podcast: GBT Technologies' CTO Discusses

New Post Public Reply Private Reply Replies (0) Message Board
trooperstocks
189
$GTCH The AI Eye Podcast: GBT Technologies' CTO Discusses qTerm Human Vital Signs Device Features and "New Paradigm" Potential of Multi-Dimensional IC Design Patent


Point Roberts, Washington and Vancouver, British Columbia--(Newsfile Corp. - November 6, 2020) - Investorideas.com, a global investor news source covering Artificial Intelligence (AI) brings you today's special edition of The AI Eye, watching stock news, deal tracker and advancements in artificial intelligence, featuring an exclusive interview with the CTO of GBT Technologies Inc. (OTC Pink: GTCH).

Listen to today's podcast on Investorideas.com
Hear the Ai Eye on Spotify

According to Danny Rittman, CTO of GBT Technologies Inc. (OTC Pink: GTCH), the company elected to release the first version of its AI-powered human vitals device, qTerm with only three of the four originally-planned features included. He explained that this was a decision made to meet the demand brought on by the COVID-19 pandemic.

"Originally, the qTerm device was planned to come out in its first release with four features - body temperature, heart rate, blood pressure and oxygen," he said. "Due to the pandemic, we wanted to push it out faster [to get] something to the market to help with the [COVID-19] virus."

This first release will feature the ability to easily measure body temperature, blood oxygen level and heart rate - measurements indicative of COVID-19 infection. Rittman explained that this data, with consent from the user, can be aggregated and put toward a worldwide 'thermal map' to alert others about potential health risks.

"This data … will be fed through the medical app to a backend program, which is where we're going to do processing, analytics and with the user's permission, we'll keep their location in," he said. "It can still be anonymous but we'll be able to alert users about "hot zones" that have people with symptoms and that could be a health risk."

In a recent press release explaining the qTerm's completed features, Rittman indicated that GBT planned "to expand the device further in the future, adding more features and AI capabilities."

"On the second release we're going to add the blood pressure feature as well," he said.

Elsewhere, it was announced that GBT Technologies has received a notice of allowance from the United States Patent and Trademark Office for its 3D, Monolithic, multi-dimensional, multi-plane, memory structure for integrated circuits patent. Rittman described the current state of integrated circuit (IC) design, and how this new patent will upgrade and enhance the technology, affording greater capabilities.

"The 3D monolithic chip patent is dealing with a new way to fabricate microchips and silicon," he said. "Today the silicon is a flat surface, and we basically build, - in layman's terms - create, or etch the chip on top of the silicon. So, we still have a flat surface, it's one plane and it's limited."

"Our patent, on that level, is actually taking this and making a new paradigm," he said. "Image it as multi-planar, so it's not just a flat surface. I can make it, for example, as a honeycomb shape where the honeycombs, or hexagons, have many additional planes to place the transistor on them. The shifting from the single plane surface to a multi-planar three-dimensional surface will significantly increase the number of transistors and the amount of circuitry that can be placed on the chip."

This multidimensional design, by increasing the silicon surface for transistors, could significantly improve the memory and functionality of microchips.

"With more area you can have a larger memory," he said. "A single chip can include terabytes instead of gigabytes, as we have today."

Rittman said in the attendant press release:

"We intend to explore various practical uses for this technology including with memory cells, micro solar cells and MEMS chips, we believe enabling larger silicon areas will create new horizons for the creation of advanced, miniaturized electro-mechanical systems like micro-sensors and micro-actuators with the goal of creating advanced AI, CPU and powerful GPUs within smaller areas."

"We predict that this is going to take some time before it comes into effect since it's an advanced task, making fabrication equipment for multi-planar chips, but this is definitely the future," he said.

Sam Mowers, Investorideas.com

Read and hear other editions of the AI Eye

For a list of artificial intelligence stocks on Investorideas.com visit here

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash and others.

About GBT Technologies Inc.

GBT Technologies Inc. (OTC Pink: GTCH) ("GBT" (http://gbtti.com) is a development-stage company which considers itself a native IoT creator, developing Internet of Things (IoT) and Artificial Intelligence (AI) enabled mobile technology platforms. GBT has a portfolio of Intellectual Property that, when commercialized, will include smart microchips, mobile and security applications and protocols, and supporting cloud software. GBT's system envisions the creation of a global mesh network. The core of the system will be its advanced microchip technology that can be installed in any mobile or fixed device worldwide. GBT envisions this system as a low-cost, secure, private mesh network between any enabled devices, providing shared processing, advanced mobile database management/sharing and enhanced mobile features as an alternative to traditional carrier services.

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .

The Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

Visit the Podcast page at Investorideas.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 28

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 34

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 36

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 38

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 62

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 47

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 45

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading

Top 5 Most Recently Viewed Articles

Mixed Markets: Analyzing Germany's Stock Performance

Updated Category News Views 211

Markets in Germany Prepare for Fluctuations As trading wrapped up on Wednesday, the German stock market exhibited a mixed bag of results. While certain sectors, such as Food & Beverages, Media, and Financial Services, reported gains, others faced setbacks. The Consumer & Cyclical, Construction, and Pharmaceuticals & Healthcare sectors saw declines, reflecting the market's...

Continue Reading
Teradyne's Q3 Earnings: Strong Performance and Future Growth Potential

Updated Category News Views 176

Teradyne's Q3 Earnings Exceed Expectations Teradyne Incorporated (NASDAQ: TER), a prominent player in automated test equipment, has released its third-quarter results, building a narrative of success and optimism. The company reported impressive sales figures of $737 million, with non-GAAP earnings per share (EPS) reaching $0.90, bolstered by a solid gross margin of...

Continue Reading
So-Young Plans to Revise ADS Ratio for Improved Trading

Updated Category News Views 163

So-Young's Strategic Shift in ADS Ratio So-Young International Inc. (NASDAQ: SY), a leading aesthetic treatment platform, has recently announced plans to change the ratio of its American depositary shares (ADSs) to Class A ordinary shares. This strategic decision aims to refine its trading dynamics, enhancing value for its shareholders. Details of the ADS Ratio Change The...

Continue Reading
Understanding Recent Developments at GitLab: Investor Insights

Updated Category News Views 78

Contextual Overview of GitLab's Recent Investor Challenges In a rapidly evolving technological landscape, GitLab Inc. stands at a critical juncture as investors navigate its latest developments and challenges. Recent announcements regarding financial performance have sparked interest and concern among stakeholders. Understanding the implications of these changes is...

Continue Reading
Celebrating 15 Years of Transformative Care at Senderra Pharmacy

Updated Category News Views 273

15 Years of Innovation in Specialty Pharmacy Senderra Specialty Pharmacy has proudly reached a remarkable milestone—15 years of providing top-tier healthcare solutions in the specialty pharmacy sector. This anniversary embodies a journey marked by significant advancements and unwavering commitment to revolutionizing patient care. Transforming Patient Experiences Since...

Continue Reading